ADVOCATE. CONNECT. INNOVATE.

CLSA Wire

Business Insider: These companies you’ve never heard of are about to incite another massive drug price outrage
Facebook
Twitter
LinkedIn

bi

Linette Lopez | Business Insider
Sep. 12, 2016

It’s easy to see why EpiPen has become the focus of America’s fury over drug prices. It treats potentially deadly allergic reactions — for example, in a child who is stung by a bee — and its price has spiked by over 500% in a few years.

While it’s easy to jump all over drugmakers, like EpiPen’s maker, Mylan, other actors in the healthcare system ought to draw as much scrutiny.

One group of companies, called pharmaceutical-benefit managers, or PBMs, serve as middlemen, and they touch every part of the purchase of a prescription drug.

And now there’s a growing realization, from Washington to Wall Street, that PBMs have been a big beneficiary of soaring drug prices burdening Americans — profits of the largest companies have doubled in recent years — even as they pitch their services as critical to controlling costs.

Read the full article at Business Insider.